HCW Biologics shares skyrocketed as the company entered a licensing agreement with China's WY Biotech for an immunotherapeutic product candidate.

China's stock market is likely headed for tougher times ahead, at least according to a few prominent Wall Street firms.

The FTSE 100 and European markets opened higher on Monday, heading higher from a dip last week where investors took profits ...

Ford has more than a century of history and innovation behind it, but now BYD, a young Chinese automaker, is barreling around ...

The Chinese e-commerce leader is issuing bonds denominated in US-dollar and yuan to help repay debt and fund stock ...

Futu Holdings (NASDAQ:FUTU) is scheduled to announce Q3 earnings results on Tuesday, November 19th, before market open. The ...

Nvidia's stock has surged more than 2,600% in the past five years according to Yahoo Finance data, fueled by one impressive ...

When we investigated some of the claims cited in the posts, we found that some were accurate, some were wrong and most of the rest omitted context ...

China stocks are struggling on tepid stimulus and fears of new Trump tariffs. Tesla rivals XPeng and BYD are among the best ...

After spending more than a hundred million dollars to help Trump get elected, Musk stands to earn a lot more. On Wednesday, ...

Halliburton’s share price has been under pressure in recent months, with headwinds in the U.S. and a potential end to OPEC+ ...

China’s cancellation of tax relief on exports has left the aluminum industry scrambling to assess the impact on supply flows, with Chinese companies suffering steep stock declines while their ...